BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31642591)

  • 1. Recent Advances and Future Prospects on Adaptive Biomaterials for Antimicrobial Applications.
    Su L; Li Y; Liu Y; An Y; Shi L
    Macromol Biosci; 2019 Dec; 19(12):e1900289. PubMed ID: 31642591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipathogenic properties and applications of low-dimensional materials.
    Shaw ZL; Kuriakose S; Cheeseman S; Dickey MD; Genzer J; Christofferson AJ; Crawford RJ; McConville CF; Chapman J; Truong VK; Elbourne A; Walia S
    Nat Commun; 2021 Jun; 12(1):3897. PubMed ID: 34162835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable antimicrobial biomaterials for local drug delivery in bone infection models.
    Caplin JD; García AJ
    Acta Biomater; 2019 Jul; 93():2-11. PubMed ID: 30654212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial-based treatments for medical device-associated infections.
    Tran N; Tran PA
    Chemphyschem; 2012 Jul; 13(10):2481-94. PubMed ID: 22517627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models.
    Liu Y; Ren Y; Li Y; Su L; Zhang Y; Huang F; Liu J; Liu J; van Kooten TG; An Y; Shi L; van der Mei HC; Busscher HJ
    Acta Biomater; 2018 Oct; 79():331-343. PubMed ID: 30172935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account.
    Kasza K; Gurnani P; Hardie KR; Cámara M; Alexander C
    Adv Drug Deliv Rev; 2021 Nov; 178():113973. PubMed ID: 34530014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of bacteria with engineered nanostructured polymeric materials: a review.
    Armentano I; Arciola CR; Fortunati E; Ferrari D; Mattioli S; Amoroso CF; Rizzo J; Kenny JM; Imbriani M; Visai L
    ScientificWorldJournal; 2014; 2014():410423. PubMed ID: 25025086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria.
    Chung PY; Khanum R
    J Microbiol Immunol Infect; 2017 Aug; 50(4):405-410. PubMed ID: 28690026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
    Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
    Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Effects of Violacein against Planktonic Cells and Biofilms of Staphylococcus aureus.
    Batista AHM; Moreira ACD; de Carvalho RM; Sales GWP; Nogueira PCN; Grangeiro TB; Medeiros SC; Silveira ER; Nogueira NAP
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28946655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of nucleic acid aptamers in microbial infections.
    Afrasiabi S; Pourhajibagher M; Raoofian R; Tabarzad M; Bahador A
    J Biomed Sci; 2020 Jan; 27(1):6. PubMed ID: 31900238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in Polymer Research to Tackle Infections and Antimicrobial Resistance.
    Konai MM; Bhattacharjee B; Ghosh S; Haldar J
    Biomacromolecules; 2018 Jun; 19(6):1888-1917. PubMed ID: 29718664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria in the respiratory tract-how to treat? Or do not treat?
    Prat C; Lacoma A
    Int J Infect Dis; 2016 Oct; 51():113-122. PubMed ID: 27776777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Approaches to Manipulating Bacterial Pathogen Biofilms: Whole-Systems Design Philosophy and Steering Microbial Evolution.
    Penn AS
    Adv Exp Med Biol; 2016; 915():347-60. PubMed ID: 27193553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of antimicrobial agents on bacterial biofilms].
    Rodríguez-Martínez JM; Pascual A
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):107-14. PubMed ID: 18341923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.